EZ STEER THERMOCOOL NAV BI-DIRECTIONAL ELECTROPHYSIOLOGY CATHETER; THERMOCOOL SMARTTOUCH BI-DIRECTIONAL NAVIGATION CATHE
Biosense Webster, Inc. · Decision date Sep 15, 2026
What did the FDA decide?
FDA posted a 30-day notice for supplement S146 to PMA P030031, filed by Biosense Webster, Inc. The notice states the change is an additional supplier for critical components. The supplement type is a process change involving manufacturer, sterilizer, packager, or supplier. The device is identified as a catheter for percutaneous cardiac ablation for atrial flutter, with product code OAD.
The notice does not describe which critical components are affected, which supplier is added, or what manufacturing steps are involved. The decision field shows OK30, but the notice does not provide a clinical or safety evaluation. A supplement notice of this kind is not an approval of the entire device system and does not establish new indications or effectiveness findings.
FDA approval order statement
an additional supplier for critical components
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P030031/S146
- Regulatory pathway
- PMA supplement
- Applicant
- Biosense Webster, Inc.
- Product code
- OAD
- Decision code
- OK30
- Decision date
- Sep 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.
- Applicant
- Biosense Webster, Inc.
- Product code
- OAD
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P030031. Subsequent supplements may change the device or its indications.
FDA decision timeline
P030031 · Original PMA
BIOSENSE WEBSTER NAVISTAR/CELSIUS THERMO COOL DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETERS
P030031/S146 received
Application receipt date recorded by FDA.
P030031/S142 · Related supplement
THERMOCOOL SMARTTOUCH SF Catheter
P030031/S146 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P030031. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P030031
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA approval | Nov 5, 2004 | FDA | |
THERMOCOOL SMARTTOUCH SF CatheterP030031/S142 | Biosense Webster, Inc. | PMA supplement | Sep 2, 2026 | FDA |
Explore the linked device profile
Other records with product code OAD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Therapy Dual-8 Ablation CatheterP040042/S060 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Sep 3, 2026 | FDA |
| Irvine Biomedical,Inc.(Ibi) | PMA approval | Nov 18, 2005 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biosense Webster, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P030031/S146
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records